You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ROSUVASTATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rosuvastatin patents expire, and what generic alternatives are available?

Rosuvastatin is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Aurobindo Pharma Ltd, Biocon Pharma, Cadila Pharms Ltd, Changzhou Pharm, Chartwell Rx, Glenmark Speclt, Hetero Labs Ltd V, Inventia, Lupin, MSN, Renata, Sandoz, Sciegen Pharms Inc, Shandong, Strides Pharma, Sun Pharm, Sunshine, Teva Pharms Usa, Torrent, Umedica, Watson Labs Inc, Zhejiang Jingxin, and Zhejiang Yongtai. and is included in twenty-seven NDAs.

The generic ingredient in ROSUVASTATIN is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rosuvastatin

A generic version of ROSUVASTATIN was approved as rosuvastatin calcium by WATSON LABS INC on April 29th, 2016.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ROSUVASTATIN?
  • What are the global sales for ROSUVASTATIN?
  • What is Average Wholesale Price for ROSUVASTATIN?
Drug patent expirations by year for ROSUVASTATIN
Drug Prices for ROSUVASTATIN

See drug prices for ROSUVASTATIN

Drug Sales Revenue Trends for ROSUVASTATIN

See drug sales revenues for ROSUVASTATIN

US Patents and Regulatory Information for ROSUVASTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shandong ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 207375-004 May 7, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zhejiang Jingxin ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 206513-001 Mar 1, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 207616-001 Oct 31, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Changzhou Pharm ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 207408-004 Oct 31, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.